Francis deSouza, Illumina CEO (Stefan Wermuth/Bloomberg via Getty Images)

Il­lu­mi­na chair­man oust­ed from board as ac­tivist in­vestor Ic­ahn wins par­tial vic­to­ry

Il­lu­mi­na’s chair­man has been oust­ed from the com­pa­ny’s board, a par­tial win for ac­tivist in­vestor Carl Ic­ahn, who is still like­ly to put the fu­ture lead­er­ship and di­rec­tion of the DNA se­quenc­ing gi­ant in­to ques­tion.

The vote to re­move chair­man John Thomp­son and put in An­drew Teno was the cli­max of a proxy fight brought by Ic­ahn af­ter Il­lu­mi­na’s stock slide and de­ci­sion to buy the can­cer-test­ing com­pa­ny Grail. Il­lu­mi­na said a new chair will be cho­sen in the com­ing weeks.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Life Sciences Senior Associate

General Catalyst

San Francisco, CA, USA